Testing effectiveness (Phase 2)Study completedNCT02344017
What this trial is testing
Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer
Who this might be right for
Prostate Cancer
Orion Corporation, Orion Pharma 23